NO990225L - Medikamenter for behandling av hyperfosfatemi - Google Patents

Medikamenter for behandling av hyperfosfatemi

Info

Publication number
NO990225L
NO990225L NO990225A NO990225A NO990225L NO 990225 L NO990225 L NO 990225L NO 990225 A NO990225 A NO 990225A NO 990225 A NO990225 A NO 990225A NO 990225 L NO990225 L NO 990225L
Authority
NO
Norway
Prior art keywords
hyperphosphatemia
drug
treatment
medications
ions
Prior art date
Application number
NO990225A
Other languages
English (en)
Other versions
NO990225D0 (no
Inventor
Yoshiyuki Sasaki
Yutaka Ishii
Original Assignee
Nikken Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nikken Chemicals Co Ltd filed Critical Nikken Chemicals Co Ltd
Publication of NO990225D0 publication Critical patent/NO990225D0/no
Publication of NO990225L publication Critical patent/NO990225L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Et medikament som omfatter som en aktiv bestanddel, en svakt bas- isk anionbytterresin som danner chelat med jern(III)ioner, fortrinnsvis en re- sin av polyamintypen eller akryltypen. Medikamentet har utmerket adsorberende evne og selektivitet for fosfationer og adsorberer effektivt fosfationer in vivo og er således anvendelig for tera- peutisk og/eller preventiv behandling av hyperfosfatemi.
NO990225A 1996-07-19 1999-01-18 Medikamenter for behandling av hyperfosfatemi NO990225L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP20757496 1996-07-19
JP3146197 1997-01-31
PCT/JP1997/002486 WO1998003185A1 (fr) 1996-07-19 1997-07-17 Remedes contre l'hyperphosphatemie

Publications (2)

Publication Number Publication Date
NO990225D0 NO990225D0 (no) 1999-01-18
NO990225L true NO990225L (no) 1999-03-18

Family

ID=26369934

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990225A NO990225L (no) 1996-07-19 1999-01-18 Medikamenter for behandling av hyperfosfatemi

Country Status (7)

Country Link
US (1) US6180094B1 (no)
EP (1) EP0922461A4 (no)
KR (1) KR20000067929A (no)
CN (1) CN1230118A (no)
CA (1) CA2261750A1 (no)
NO (1) NO990225L (no)
WO (1) WO1998003185A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001066607A1 (fr) * 2000-03-09 2001-09-13 Hisamitsu Pharmaceutical Co., Inc. Resine echangeuse d'anions reticulee ou sel de celle-ci et adsorbant phosphoreux la contenant
WO2001066606A1 (fr) * 2000-03-09 2001-09-13 Hisamitsu Pharmaceutical Co., Inc. Resine echangeuse d'anions reticulee ou sel de celle-ci
CA2542968C (en) * 2003-10-20 2013-06-04 Framework Therapeutics, L.L.C. Zeolite molecular sieves for the removal of toxins
US7335795B2 (en) * 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
CA2551528A1 (en) * 2003-12-31 2005-07-21 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
EP3574896A1 (en) 2004-03-30 2019-12-04 Relypsa, Inc. Ion binding polymers and uses thereof
EP1830832A1 (en) * 2004-12-30 2007-09-12 Genzyme Corporation Zinc-containing treatments for hyperphosphatemia
CA2620406A1 (en) 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
WO2007056405A2 (en) * 2005-11-08 2007-05-18 Genzyme Corporation Magnesium-containing polymers for the treatment of hyperphosphatemia
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
CN100398112C (zh) * 2006-03-24 2008-07-02 辽宁诺康生物制药有限责任公司 一种治疗血磷酸盐过多症的药物及其制备方法
JP2009542653A (ja) * 2006-07-05 2009-12-03 ジェンザイム コーポレーション リン酸塩過剰血症のための鉄（ｉｉ）含有治療剤
ES2573636T3 (es) * 2006-10-25 2016-06-09 Wisconsin Alumni Research Foundation Métodos para reducir la absorción de fosfato empleando un anticuerpo anti-Npt2B
BRPI0716317A8 (pt) * 2006-10-26 2019-02-05 Aovatechnologies Inc método para reduzir a absorção de fosfato em um indivíduo animal humano ou não-humano e método para reduzir a absorção de fosfato em um indivíduo humano
CA2625522A1 (en) 2007-04-20 2008-10-20 Rohm And Haas Company Method for removing phosphate from aqueous solutions
AU2010276242B2 (en) 2009-07-21 2014-05-29 Keryx Biopharmaceuticals, Inc. Ferric citrate dosage forms
WO2011125758A1 (ja) * 2010-03-31 2011-10-13 富田製薬株式会社 透析組成物、血液透析システムおよび血液透析器
EP2673626A1 (en) 2011-02-11 2013-12-18 Colgate-Palmolive Company Methods of analyzing plaque
AU2013278000A1 (en) * 2012-06-21 2015-01-22 Keryx Biopharmaceuticals, Inc. Use of ferric citrate in the treatment of chronic kidney disease patients
TWI653043B (zh) * 2012-12-20 2019-03-11 瑞士商伊蘭科動物健康公司 新用途
CN104258829B (zh) * 2014-09-24 2016-08-31 珠海健帆生物科技股份有限公司 血磷吸附剂及其制备方法、用于血液灌流的吸附柱
CN111773247B (zh) * 2020-07-24 2022-04-05 荆门市第一人民医院 蔗糖铁在制备治疗高磷血症诱导的血管钙化药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228231A1 (de) * 1982-07-28 1984-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung
CA2042870C (en) * 1991-05-17 1996-11-26 Leon Edward St. Pierre Metal ion coordinated polyamine resins for the lowering of blood cholesterol
US5487888A (en) 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
JPH072903A (ja) * 1993-06-11 1995-01-06 Tatsuaki Yamaguchi アセチル化鉄キトサン錯体、その製法および用途
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
JPH09157283A (ja) * 1995-12-13 1997-06-17 Tatsuaki Yamaguchi 燐酸吸着コロイド
ES2162658T3 (es) * 1996-03-05 2002-01-01 Mitsubishi Chem Corp Utilizacion de resinas intercambiadoras anionicas para la fabricacion de un medicamento destinado al tratamiento de la hiperfosfatemia.

Also Published As

Publication number Publication date
WO1998003185A1 (fr) 1998-01-29
EP0922461A1 (en) 1999-06-16
EP0922461A4 (en) 2002-07-17
CA2261750A1 (en) 1998-01-29
CN1230118A (zh) 1999-09-29
US6180094B1 (en) 2001-01-30
NO990225D0 (no) 1999-01-18
KR20000067929A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
NO990225L (no) Medikamenter for behandling av hyperfosfatemi
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
CA2282654A1 (en) Use of cholinesterase inhibitors to treat attention deficit hyperactivity disorder
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
CA2433341A1 (en) Method and system for reducing microbial burden on a food product
DK1039887T3 (da) Anvendelse af aminothiolforbindelser til behandling af neuro- og nefrolidelser og terapeutiske toksiciteter
EP0509317A3 (en) Use of droloxifene in the treatment of bone diseases
AU2002321105A1 (en) Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
EP1140840A4 (en) DIPHENYLUREA WITH SUBSTITUENTS -G (V) -CARBOXYARYLES, INHIBITORS OF RAF KINASE
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
ZA200005217B (en) α-sulfonylamino hydroxamic acid inhibitors of matrix metalloproteinases for the treatment of peripheral or central nervous system disorders.
DE68914436T2 (de) Therapeutisches system zum plasmaaustausch.
DK0840606T3 (da) Små di- og trivalente molekyler som selectininhibitorer
CA2344407A1 (en) Method for the treatment of mania and bipolar disorder
WO2004110380A3 (en) Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents
CA2176298A1 (en) A single high dose fluoroquinolone treatment
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
CA2380078A1 (en) Combination therapy using pentafluorobenzenesulfonamides
NO990282L (no) Absorbsjonsforsterker
AU3260093A (en) Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours
ZA877901B (en) Active compounds for use in the treatment of tumors
MY117960A (en) A new salt
ES2086359T3 (es) R(-)-1-(5-hidroxihexil)-3-metil-7-propilxantina, procedimiento para su preparacion y medicamentos que contienen este compuesto.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application